References
- Marioni G, Gaio E, Giacomelli L, Marchese-Ragona R, Staffieri C, Staffieri A, et al. Endoglin (CD105) expression in basaloid squamous cell carcinoma of head and neck. Acta Otolaryngol (Stockh) 2005; 125: 307–11
- Hobson B, Denekamp J. Endothelial proliferation in tumors and normal tissues: continuous labelling studis. Br J Cancer 1984; 49: 405–13
- Schimming R, Marmè D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 2002; 24: 151–6
- Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984–92
- Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003; 22: 6557–63
- Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2004; 2: 18
- International Union Against Cancer. TNM classification of malignant tumours5th edn. Wiley-Liss, New York 1997
- Shieh Y-S, Lee H-S, Shiah S-G, Chu Y-W, Wu C-H, Chang L-C. Role of angiogenic and non-angiogenic mechanisms in oral squamous cell carcinoma: correlation with histologic differentiation and tumor progression. J Oral Pathol Med 2004; 33: 601–6
- Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Hönigshnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003; 23: 455–60
- Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K-i, Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 2004; 40: 13–20
- Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 2002; 62: 7124–9
- Schimming R, Reusch P, Kuschnierz J, Schmelzeisen R. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?. J Cranio-Maxillofac Surg 2004; 32: 176–81
- Nagatsuka H, Hibi K, Gunduz M, Tsujigiwa H, Tamamura R, Sugahara T, et al. Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinomas. J Oral Pathol Med 2005; 34: 70–6
- Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, et al. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 2005; 41: 147–55
- Shiozaki, K, Harada, N, Greco, WR, Haba, A, Uneda, S, Tsai, H, et al. Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in non human primates and effects of doxorubicin. Cancer Immunol Immunother 2006;55;140–50.